中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
25期
59-62
,共4页
度洛西汀%艾司西酞普兰%抑郁症%安全性
度洛西汀%艾司西酞普蘭%抑鬱癥%安全性
도락서정%애사서태보란%억욱증%안전성
Duloxetine%Escitalopram%Depression%Safety
目的:探讨对抑郁症患者使用度洛西汀联合艾司西酞普兰治疗的临床效果。方法:选取本院精神科和中山市人民医院心理科收治的抑郁症患者128例作为研究对象,对照组1(40例)使用度洛西汀治疗,对照组2(40例)使用艾司西酞普兰治疗,观察组48例联合使用上述药物,对比三组临床效果。结果:观察组治疗总有效率为83.3%,高于对照组1的72.5%与对照组2的75.0%,比较差异有统计学意义(P<0.05);治疗后观察组HAMD评分显著低于对照组1、2,比较差异有统计学意义(P<0.05);三组不良反应发生率比较差异无统计学意义(P>0.05)。结论:对抑郁症患者使用度洛西汀联合艾司西酞普兰治疗效果明显,有推广价值。
目的:探討對抑鬱癥患者使用度洛西汀聯閤艾司西酞普蘭治療的臨床效果。方法:選取本院精神科和中山市人民醫院心理科收治的抑鬱癥患者128例作為研究對象,對照組1(40例)使用度洛西汀治療,對照組2(40例)使用艾司西酞普蘭治療,觀察組48例聯閤使用上述藥物,對比三組臨床效果。結果:觀察組治療總有效率為83.3%,高于對照組1的72.5%與對照組2的75.0%,比較差異有統計學意義(P<0.05);治療後觀察組HAMD評分顯著低于對照組1、2,比較差異有統計學意義(P<0.05);三組不良反應髮生率比較差異無統計學意義(P>0.05)。結論:對抑鬱癥患者使用度洛西汀聯閤艾司西酞普蘭治療效果明顯,有推廣價值。
목적:탐토대억욱증환자사용도락서정연합애사서태보란치료적림상효과。방법:선취본원정신과화중산시인민의원심이과수치적억욱증환자128례작위연구대상,대조조1(40례)사용도락서정치료,대조조2(40례)사용애사서태보란치료,관찰조48례연합사용상술약물,대비삼조림상효과。결과:관찰조치료총유효솔위83.3%,고우대조조1적72.5%여대조조2적75.0%,비교차이유통계학의의(P<0.05);치료후관찰조HAMD평분현저저우대조조1、2,비교차이유통계학의의(P<0.05);삼조불량반응발생솔비교차이무통계학의의(P>0.05)。결론:대억욱증환자사용도락서정연합애사서태보란치료효과명현,유추엄개치。
Objective: To explore the clinical effect of duloxetine in combination of escitalopram for patients with depression.Method: 128 patients who were admitted in the psychiatry department of our hospital and psychological department of Zhongshan People’s Hospital were chosen as research objects. They were divided into control group 1 (40 patients), control group 2 (40 patients), and observation group (48 patients). Patients in the control group 1 were cured with the application of duloxetine, and the control group 2 with escitalopram while patients in the observation group were cured with combination of the two kinds of medicine. The clinical effect of the three groups was compared.Result: The total effective rate of the observation group was 83.3%, which was higher than 72.5% of the control group 1, and 75.0% of the control group 2. The difference was statistically significant (P<0.05). After treatment, HAMD grade of the observation groupwas remarkably lower than that of the two control groups, which had statistical significance (P<0.05). The contrast difference in incidence of adverse reactions of the three groups had no statistical significance (P>0.05).Conclusion: Duloxetine in combination of escitalopram for patients with depression has obvious clinical effect. It is worth of promotion.